MapLight Therapeutics MPLT
NASDAQ MPLT
$8.42 +0.18 (+2.21%)
As of: Oct 21, 2026 · 1:51 PM EDT

MapLight Therapeutics (MPLT) EBT (2024 - 2026)

Updated

MapLight Therapeutics (MPLT) recorded EBT of -$61.2 million in Q2 2026, compared with -$29.98 million a year earlier.

Analysis

MapLight Therapeutics (MPLT) EBT (2024 - 2026) Analysis & Trends

On a TTM basis, MapLight Therapeutics' EBT came in at -$202.03 million as of Jun 30, 2026; for FY2025, it came in at -$163.57 million.

  • Across earlier years, EBT came in at -$78.44 million in FY2024.
  • Quarterly EBT has ranged from -$80.91 million in Q4 2025 to -$19.81 million in Q3 2024 over the past five years.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBT (Qtr)
1 Eli Lilly 1,134.24 Bn 1,102.83 Bn 19.71 Bn 9.25 Bn
2 Johnson & Johnson 616.05 Bn 534.58 Bn 17.26 Bn 6.75 Bn
3 AbbVie 500.90 Bn 474.01 Bn 12.70 Bn 4.28 Bn
4 Merck 367.17 Bn 321.54 Bn 12.21 Bn -683.00 Mn
5 Novartis Ag 297.85 Bn 261.84 Bn 11.24 Bn 4.27 Bn
6 Astrazeneca 261.35 Bn 235.03 Bn 12.86 Bn 2.80 Bn
7 Amgen 235.77 Bn 191.17 Bn 7.24 Bn 2.77 Bn
8 Gilead Sciences 190.70 Bn 164.90 Bn 6.22 Bn -10.25 Bn
9 Pfizer 169.35 Bn 115.99 Bn 10.94 Bn -653.00 Mn
10 MapLight Therapeutics 383.21 Mn 383.21 Mn - -61.20 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -61.20 Mn
Dec 31, 2025 -80.91 Mn
Sep 30, 2025 -29.95 Mn
Jun 30, 2025 -29.98 Mn
Dec 31, 2024 -21.88 Mn
Sep 30, 2024 -19.81 Mn
API Access

MapLight Therapeutics EBT API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=ebt&ticker=MPLT&period=max&api_key=YOUR_API_KEY